There was a statistical trend (0.062) towards less use of betablocker therapy in the LBD group versus the AD group, and numerically greater use of angiotensin-converting enzyme inhibitors or angiotensin receptor blocker therapy.
← all excerpts
High prevalence of atrial conduction abnormalities in Lewy body disease - a marker of cardiac complications?
1
—
—